SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-23-001309
Filing Date
2023-05-22
Accepted
2023-05-22 16:47:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d07422pirs_05222023.htm SC 13D 325405
2 JOINT FILING AGREEMENT, DATED MAY 22, 2023 ex991to13d07422pirs_05222023.htm EX-99.1 8095
  Complete submission text file 0000921895-23-001309.txt   335177
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88917 | Film No.: 23945218
SIC: 2834 Pharmaceutical Preparations